相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphael Itzykson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Mutations and prognosis in primary myelofibrosis
A. M. Vannucchi et al.
LEUKEMIA (2013)
Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
Wendy W. Pang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Two Novel Patients With Bohring-Opitz Syndrome Caused by De Novo ASXL1 Mutations
Pamela Magini et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2012)
Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
Satomi Tanaka et al.
BLOOD (2012)
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations
Britta Will et al.
BLOOD (2012)
ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
Omar Abdel-Wahab et al.
CANCER CELL (2012)
Ezh1 Is Required for Hematopoietic Stem Cell Maintenance and Prevents Senescence-like Cell Cycle Arrest
Isabel Hidalgo et al.
CELL STEM CELL (2012)
Genome-wide Analysis of Myelodysplastic Syndromes
Masashi Sanada et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events
Claudia Haferlach et al.
GENES CHROMOSOMES & CANCER (2012)
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
Rafael Bejar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Jay P. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation
Anwesha Dey et al.
SCIENCE (2012)
The role of mutations in epigenetic regulators in myeloid malignancies
Alan H. Shih et al.
NATURE REVIEWS CANCER (2012)
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
Anna M. Jankowska et al.
BLOOD (2011)
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
Klaus H. Metzeler et al.
BLOOD (2011)
Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
Zhe Li et al.
BLOOD (2011)
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
Cyril Quivoron et al.
CANCER CELL (2011)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
Felicitas Thol et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia
Apostolos Klinakis et al.
NATURE (2011)
De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome
Alexander Hoischen et al.
NATURE GENETICS (2011)
Germline deletion of the miR-17∼92 cluster causes skeletal and growth defects in humans
Loic de Pontual et al.
NATURE GENETICS (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
Myunggon Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia
Cynthia L. Fisher et al.
BLOOD (2010)
Additional sex combs-like 1 belongs to the enhancer of trithorax and polycomb group and genetically interacts with Cbx2 in mice
C. L. Fisher et al.
DEVELOPMENTAL BIOLOGY (2010)
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
J. Boultwood et al.
LEUKEMIA (2010)
Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission
Ramin Tehranchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
Veronique Gelsi-Boyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Impaired differentiation and apoptosis of hematopoietic precursors in a mouse model of myelodysplastic syndrome
Chul Won Choi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
The molecular signature of MDS stem cells supports a stem-cell origin of 5q -: myelodysplastic syndromes
Lars Nilsson et al.
BLOOD (2007)
Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias
C. G. Mullighan et al.
LEUKEMIA (2007)
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells
Adrian P. Bracken et al.
GENES & DEVELOPMENT (2007)
Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells
Ulrich Steidl et al.
NATURE GENETICS (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia
YW Lin et al.
BLOOD (2005)
Role of transcription factors C/EBPα and PU.1 in normal hematopoiesis and leukemia
S Koschmieder et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing
M Stadtfeld et al.
DEVELOPMENT (2005)
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
F Rosenbauer et al.
NATURE GENETICS (2004)
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling
ME Ross et al.
BLOOD (2003)
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations
M Mizuki et al.
BLOOD (2003)
The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia
RK Vangala et al.
BLOOD (2003)
Stemness: Transcriptional profiling of embryonic and adult stem cells
M Ramalho-Santos et al.
SCIENCE (2002)
Heterozygous PU.1 mutations are associated with acute myeloid leukemia
BU Mueller et al.
BLOOD (2002)
Polycomb group gene rae28 is required for sustaining activity of hematopoietic stem cells
H Ohta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
分享论文
